治験レーダーAI | ||
|---|---|---|
治験 NCT07255131 (RAKITZIHCFA)（対象：Depression - Major Depressive Disorder、Anxiety Chronic、不安、機能的転帰、回復、Obsessive Compulsive Disorders、Assertiveness）は募集中です。詳細は治験レーダーのタイル表示と AI 発見ツールで確認するか、ここで質問してください。 | ||
フィルター基準に一致する試験が1件見つかりました
タイル表示
The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program (RAKITZIHCFA)
治験(臨床試験)の詳細は主に英語で提供されています。しかし、治験レーダーAIが支援できます！「治験を説明」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT07255131 (RAKITZIHCFA) は 介入研究 臨床試験 で、Depression - Major Depressive Disorder、Anxiety Chronic、不安、機能的転帰、回復、Obsessive Compulsive Disorders、Assertiveness に関するものです。現在は 募集中 で、2025年9月26日 から開始しています。52 名の参加者 の募集が計画されています。この治験は Rakitzi, Stavroula によって主催され、2028年12月20日 に完了予定です。ClinicalTrials.gov からの最新更新日は 2025年11月28日 です。
概要
An online group cognitive behavioral psychotherapeutic program will be offered to patients with cystic fibrosis and to caregivers by the Hellenic Cystic Fibrosis Association. These 2 above therapy groups will be compared with control groups in a randomized controlled trial
詳細説明
A therapy group of patients with cystic fibrosis, who participate on the online group cognitive behavioral psychotherapeutic program will be compared with a control group of patients with cystic fibrosis, who participate in an online group supportive psychotherapeutic program. Both of the groups participate on 13 sessions once a week.
A therapy group of caregivers, who participate on the online group cognitive behavioral psychotherapeutic program will be compared with a control group of caregivers, who participate in an online group supportive psychotherapeutic program. Both of the groups participate on 13 sessions once a week.
公式タイトル
The Effectiveness and Efficacy of an Online Group Cognitive Behavioral Psychotherapy in Patients With Cystic Fibrosis and Caregivers in Comparison to Control Groups by the Hellenic Cystic Fibrosis Association A Randomized Controlled Trial
疾患／病気
Depression - Major Depressive DisorderAnxiety Chronic不安機能的転帰回復Obsessive Compulsive DisordersAssertiveness刊行物
この臨床試験について発表された科学記事と研究論文：- Rakitzi, S., Spinou, A., & Giannaki, K. (2025). The effectiveness of an online-group cognitive behavioral psychotherapy in Hellenic Cystic Fibrosis Association for patients and caregivers. Journal of rational emotive and cognitive behavior therapy. DOI: 10.1007/s10942-025-00611-3
- Rakitzi, S. (2023). Clinical psychology and cognitive behavioral psychotherapy. Recovery in mental health. Springer.
- Mayr, S., Erdfelder, E., Buchner, A., & Faul, F. (2007). A short tutorial of G-Power. Tutorials in Quantitative Methods in Psychology, 3(2), 51-59.
- Koumpouros, Y., Papageorgiou, E., Sakellari, E., Prapas, X., Perifanou, D., & Lagiou, A. (2018). Adaptation and psychometric properties' evaluation of the Greek version of WHODAS 2.0. Pilot application in Greek elderly population. Health Services and Outcomes Research Methodology, 18(1), 63-74. https://doi.org/10.1007/s10742-017-0176-x.
- Hofmann SG, Asnaani A, Vonk IJ, Sawyer AT, Fang A. The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses. Cognit Ther Res. 2012 Oct 1;36(5):427-440. doi: 10.1007/s10608-012-9476-1. Epub 2012 Jul 31.
- Hancock N, Scanlan JN, Honey A, Bundy AC, O'Shea K. Recovery Assessment Scale - Domains and Stages (RAS-DS): Its feasibility and outcome measurement capacity. Aust N Z J Psychiatry. 2015 Jul;49(7):624-33. doi: 10.1177/0004867414564084. Epub 2014 Dec 19.
- HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56. No abstract available.
- Fountoulakis KN, Iacovides A, Kleanthous S, Samolis S, Gougoulias K, St Kaprinis G, Bech P. The Greek translation of the symptoms rating scale for depression and anxiety: preliminary results of the validation study. BMC Psychiatry. 2003 Dec 10;3:21. doi: 10.1186/1471-244X-3-21.
- Fiedler, P. (2005). Verhaltenstherapie in Gruppen. Beltz.
- Cohen, J. (1988). Statistical Power Analyses for the Behavioural Sciences. Erlbaum.
- Bech, P. (1993). Rating scales for Psychopathology, Health Status and Quality of Life. Springer-Verlag.
- Αntoniou, V., Εfthimiou, Κ., & Μilona, Κ.(2015). Social anxiety and assertiveness. A structured group cognitive behavioral program. IETHS.
その他の研究識別子
- RAKITZIHCFA
- RAKITZI CYSTIC FIBROSIS
- HELLENIC CYSTIC FIBROSIS ASSOC (その他の識別子) (HELLENIC CYSTIC FIBROSIS ASSOCIATION & DR. STAVROULA RAKITZI)
NCT番号
開始日
2025-09-26
最終更新日
2025-11-28
終了予定日
2028-12-20
目標参加者数
52
試験の種類
介入研究
治験の相・段階
該当なし
状況
募集中
キーワード
Cystic Fibrosis
Group cognitive behavioral psychotherapy
Group cognitive behavioral psychotherapy
主目的
治療
割付方法
無作為化
介入モデル
並行割当
盲検化
単盲検
群（アーム）／介入
| 参加グループ/群 | 介入/治療法 |
|---|---|
実験的Therapy group A patients with Cystic Fibrosis Participation on an online group cognitive behavioral psychotherapy via Zoom in 13 sessions. | Group a an Online Group Cognitive Behavioral Psychotherapy in 13 Sessions Via Zoom An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy Group A, to patients with cystic fibrosis |
実薬対照薬Control group B Patients with cystic fibrosis Participation on an online group supportive psychotherapy via Zoom in 13 sessions. | Group B an Online Group Supportive Psychotherapy in 13 Sessions Via Zoom An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control group Group B, to patients with cystic fibrosis |
実験的Therapy group C caregivers of patients with cystic fibrosis Participation on an online group cognitive behavioral psychotherapy via Zoom in 13 sessions. | Group C an Online Group Cognitive Behavioral Psychotherapy in 13 Sessions Via Zoom An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy group C, to caregivers of patients with cystic fibrosis |
実薬対照薬Contol group D caregivers of patients with cystic fibrosis Participation on an online group supportive psychotherapy via Zoom in 13 sessions. | Group D an Online Group Supportive Psychotherapy in 13 Sessions Via Zoom An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control Group D, to caregivers of patients with cystic fibrosis |
主要評価項目
| 評価指標 | 指標の説明 | 時間枠 |
|---|---|---|
SCL-90-R | It evaluates psychopathology. T\>60 means psychopathology. Low scores better | Preintervention |
SCL-90-R | It evaluates psychopathology. T\>60 means psychopathology. Low scores better | Immediately after the intervention |
SCL-90-R | It evaluates psychopathology. T\>60 means psychopathology. Low scores better | Follow-up up to 24 weeks |
SRSDA | It measures Depression. Minimum 0 Maximum over 14. Low scores better | Preintervention |
SRSDA | It measures Depression. Minimum 0 Maximum over 14. Low scores better | Immediately after intervention |
SRSDA | It measures Depression. Minimum 0 Maximum over 14. Low scores better | Follow-up up to 24 weeks |
SRSDA | It measures anxiety. Minimum 0 Maximum over 10. Low scores better | Preintervention |
SRSDA | It measures anxiety. Minimum 0 Maximum over 10. Low scores better | Immediately after intervention |
SRSDA | It measures anxiety. Minimum 0 Maximum over 10. Low scores better | Follow-up up to 24 weeks |
U Uncertainty questionnaire | It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9) | Preintervention |
U Uncertainty questionnaire | It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9) | Immediately after the intervention |
U Uncertainty questionnaire | It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9) | Follow up up to 24 weeks |
Hamilton Depression Scale | It measures depression. Minimum 0, maximum 23. Low scores better. | Preintervention |
Hamilton Depression Scale | It measures depression. Minimum 0, maximum 23. Low scores better. | Immediately after the intervention |
Hamilton Depression Scale | It measures depression. Minimum 0, maximum 23. Low scores better. | Follow up up to 24 weeks |
WHODAS total | It measures functional outcome. Minimum 0, maximum 100. low scores better. | Preintervention |
WHODAS total | It measures functional outcome. Minimum 0, maximum 100. low scores better. | Immediately after the intervention |
WHODAS total | It measures functional outcome. Minimum 0, maximum 100. low scores better. | Follow up up to 24 weeks |
RAS-DS total | Recovery. It measures recovery. Minimum 0, maximum 152. High scores better. | Preintervention |
RAS-DS total | Recovery. It measures recovery. Minimum 0, maximum 152. High scores better. | Immediately after intervention |
RAS-DS total | Recovery. It measures recovery. Minimum 0, maximum 152. High scores better. | Follow up up to 24 weeks |
適格基準
対象年齢
成人, 高齢者
試験の最低年齢
18 Years
対象性別
全て
- Age 18-70
- Members of the Hellenic Cystic Fibrosis Association
- Willingness to participate on 13 sessions via Zoom
- Age over 70
- Not members of the Hellenic Cystic Fibrosis Association
- Not able to participate on 13 sessions via Zoom
Rakitzi, Stavroula責任者
Dr. Stavroula Rakitzi, 研究責任者, PhD, Clinical psychologist and cognitive behavioral psychotherapist, Rakitzi, Stavroula
試験中央連絡先
連絡先: Dr. Stavroula Rakitzi, PhD, +306989766935, [email protected]
連絡先: Mrs Anna Spinou, President of the Hellenic Cystic Fibrosis Association, Msc, +306944255853, [email protected]
1 1カ国の場所
Private practice, ILISION 34 15771 Athens Greece, Athens, 15771, Greece
Dr. Stavroula Rakitzi, PhD, 連絡先, +306989766935, [email protected]
Mrs Anna Spinou, President of the Hellenic Cystic Fibrosis Association, Msc, 連絡先, +306944255853, [email protected]
募集中